Announcements Trials
Browse Landscape

Phase

Phase NA 4

Status

Completed 3Not yet recruiting 1

Sponsor Class

OTHER 4NETWORK 1

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 10Tumor-Agnostic 4Other solid neoplasm 3Lymphoid 3Gynecologic 3Gastrointestinal 3Other 2Plasma cell 1Other neoplasm 1Other hematologic neoplasm 1Myeloid 1Dermatologic 1CNS 1

Conditions

Neoplasms 3Neoplasm Metastasis 1

Interventions

Surveys and Questionnaires 70Blood Specimen Collection 48Radiotherapy 39Magnetic Resonance Spectroscopy 35pembrolizumab 31Gemcitabine 30Bevacizumab 30Nivolumab 29Carboplatin 29Radiosurgery 27Standard of Care 26Oxaliplatin 26Capecitabine 25Paclitaxel 24Interviews as Topic 24Cisplatin 24Fluorouracil 23Erlotinib Hydrochloride 22Everolimus 19Irinotecan 18Trastuzumab 17Methods 17Exercise 17Docetaxel 17Biopsy 17Cyclophosphamide 16Educational Status 15Sorafenib 14Ipilimumab 14Fluorodeoxyglucose F18 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Mindfulness × Tumor-Agnostic × Clear all
NCT07124481 2025-08-15

EarlyMind

Isala

Phase NA Not yet recruiting
208 enrolled
Tumor-Agnostic

Neoplasms

NCT03557762 2022-05-23

The SEAMLESS Study: Smartphone App-based Mindfulness for Cancer Survivors

University of Calgary

Phase NA Completed
83 enrolled
Tumor-Agnostic

Neoplasms

NCT03446092 2022-05-12

Mindfulness for People With Incurable Cancer

Lancaster University

Phase NA Completed
3 enrolled
Tumor-Agnostic

Neoplasms

NCT03257007 2020-08-12

MEANING

Indiana University

Phase NA Completed
108 enrolled
Tumor-Agnostic

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡